Titre : Imagerie tridimensionnelle

Imagerie tridimensionnelle : Questions médicales fréquentes

Termes MeSH sélectionnés :

Developing Countries
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Imagerie tridimensionnelle : Questions médicales les plus fréquentes", "headline": "Imagerie tridimensionnelle : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Imagerie tridimensionnelle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-18", "dateModified": "2025-02-12", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Imagerie tridimensionnelle" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Traitement d'image par ordinateur", "url": "https://questionsmedicales.fr/mesh/D007091", "about": { "@type": "MedicalCondition", "name": "Traitement d'image par ordinateur", "code": { "@type": "MedicalCode", "code": "D007091", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "L01.224.308" } } }, "about": { "@type": "MedicalCondition", "name": "Imagerie tridimensionnelle", "alternateName": "Imaging, Three-Dimensional", "code": { "@type": "MedicalCode", "code": "D021621", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Quan Yuan", "url": "https://questionsmedicales.fr/author/Quan%20Yuan", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China." } }, { "@type": "Person", "name": "Yasashri Ranathunga", "url": "https://questionsmedicales.fr/author/Yasashri%20Ranathunga", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Wayne State University, Detroit, Michigan 48202, USA." } }, { "@type": "Person", "name": "Suk Kyoung Lee", "url": "https://questionsmedicales.fr/author/Suk%20Kyoung%20Lee", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Wayne State University, Detroit, Michigan 48202, USA." } }, { "@type": "Person", "name": "Wen Li", "url": "https://questionsmedicales.fr/author/Wen%20Li", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Wayne State University, Detroit, Michigan 48202, USA." } }, { "@type": "Person", "name": "Myungjin Cho", "url": "https://questionsmedicales.fr/author/Myungjin%20Cho", "affiliation": { "@type": "Organization", "name": "School of ICT, Robotics and Mechanical Engineering, Institute of Information and Telecommunication Convergence (IITC), Hankyong National University, 327 Chungang-ro, Anseong 17579, Kyonggi-do, Republic of Korea." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "[Planning, Reflecting and Evaluating Participatory Health Research: Adaptation and Piloting of the \"Community Based Participatory Research (CBPR) Model\" for German-Speaking Countries].", "datePublished": "2023-12-21", "url": "https://questionsmedicales.fr/article/38128570", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/a-2167-2100" } }, { "@type": "ScholarlyArticle", "name": "Relationship between methods of monitoring training load and physiological indicators changes during 4 weeks cross-country skiing altitude training.", "datePublished": "2023-12-15", "url": "https://questionsmedicales.fr/article/38100499", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0295960" } }, { "@type": "ScholarlyArticle", "name": "Unmet supportive care needs among cancer patients in Sub-Saharan African countries: a mixed method systematic review and meta-analysis.", "datePublished": "2023-12-01", "url": "https://questionsmedicales.fr/article/38043746", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jpainsymman.2023.11.023" } }, { "@type": "ScholarlyArticle", "name": "Videolaryngoscopy use before and after the initial phases of the COVID-19 pandemic: The report of the VL-iCUE survey with responses from 96 countries.", "datePublished": "2023-11-29", "url": "https://questionsmedicales.fr/article/37962353", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/EJA.0000000000001922" } }, { "@type": "ScholarlyArticle", "name": "Prognostic impact of pre-referral tumor resection in unilateral Wilms tumor: A single-institute experience from a lower middle-income country.", "datePublished": "2023-11-14", "url": "https://questionsmedicales.fr/article/37962283", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/pbc.30760" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Sciences de l'information", "item": "https://questionsmedicales.fr/mesh/D007254" }, { "@type": "ListItem", "position": 3, "name": "Méthodologies informatiques", "item": "https://questionsmedicales.fr/mesh/D003205" }, { "@type": "ListItem", "position": 4, "name": "Traitement d'image par ordinateur", "item": "https://questionsmedicales.fr/mesh/D007091" }, { "@type": "ListItem", "position": 5, "name": "Imagerie tridimensionnelle", "item": "https://questionsmedicales.fr/mesh/D021621" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Imagerie tridimensionnelle - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Imagerie tridimensionnelle", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Imagerie tridimensionnelle", "description": "Quels examens utilisent l'imagerie 3D ?\nComment l'imagerie 3D aide-t-elle au diagnostic ?\nL'imagerie 3D est-elle utilisée en oncologie ?\nPeut-on détecter des anomalies avec l'imagerie 3D ?\nL'imagerie 3D est-elle utile pour les fractures ?", "url": "https://questionsmedicales.fr/mesh/D021621?mesh_terms=Developing+Countries&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Imagerie tridimensionnelle", "description": "Quels symptômes peuvent nécessiter une imagerie 3D ?\nL'imagerie 3D peut-elle aider à évaluer des douleurs abdominales ?\nQuels symptômes cardiaques peuvent être évalués par imagerie 3D ?\nL'imagerie 3D est-elle utile pour les troubles respiratoires ?\nPeut-on détecter des anomalies cérébrales avec l'imagerie 3D ?", "url": "https://questionsmedicales.fr/mesh/D021621?mesh_terms=Developing+Countries&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Imagerie tridimensionnelle", "description": "L'imagerie 3D peut-elle aider à la détection précoce des maladies ?\nComment l'imagerie 3D contribue-t-elle à la prévention des cancers ?\nPeut-on utiliser l'imagerie 3D pour le dépistage ?\nL'imagerie 3D aide-t-elle à évaluer les risques cardiovasculaires ?\nPeut-on prévenir des maladies avec l'imagerie 3D ?", "url": "https://questionsmedicales.fr/mesh/D021621?mesh_terms=Developing+Countries&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Imagerie tridimensionnelle", "description": "L'imagerie 3D est-elle utilisée pour planifier des interventions chirurgicales ?\nComment l'imagerie 3D aide-t-elle en radiothérapie ?\nPeut-on utiliser l'imagerie 3D pour guider des biopsies ?\nL'imagerie 3D est-elle utile pour le suivi des traitements ?\nPeut-on utiliser l'imagerie 3D pour des traitements non invasifs ?", "url": "https://questionsmedicales.fr/mesh/D021621?mesh_terms=Developing+Countries&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Imagerie tridimensionnelle", "description": "Quelles complications peuvent survenir avec l'imagerie 3D ?\nL'imagerie 3D peut-elle causer des effets secondaires ?\nY a-t-il des risques liés à l'utilisation d'agents de contraste ?\nL'imagerie 3D peut-elle entraîner des faux positifs ?\nQuelles sont les complications possibles après une biopsie guidée par imagerie 3D ?", "url": "https://questionsmedicales.fr/mesh/D021621?mesh_terms=Developing+Countries&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Imagerie tridimensionnelle", "description": "Quels facteurs augmentent le besoin d'imagerie 3D ?\nL'âge est-il un facteur de risque pour l'imagerie 3D ?\nLe tabagisme influence-t-il le besoin d'imagerie 3D ?\nLes antécédents médicaux influencent-ils l'imagerie 3D ?\nY a-t-il des facteurs environnementaux affectant l'imagerie 3D ?", "url": "https://questionsmedicales.fr/mesh/D021621?mesh_terms=Developing+Countries&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Quels examens utilisent l'imagerie 3D ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "La tomodensitométrie (CT) et l'IRM sont couramment utilisés." } }, { "@type": "Question", "name": "Comment l'imagerie 3D aide-t-elle au diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet une visualisation détaillée des organes et des tissus, facilitant le diagnostic." } }, { "@type": "Question", "name": "L'imagerie 3D est-elle utilisée en oncologie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est essentielle pour localiser et évaluer les tumeurs." } }, { "@type": "Question", "name": "Peut-on détecter des anomalies avec l'imagerie 3D ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle permet de détecter des anomalies structurelles avec précision." } }, { "@type": "Question", "name": "L'imagerie 3D est-elle utile pour les fractures ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle aide à visualiser les fractures complexes et leur impact sur les tissus environnants." } }, { "@type": "Question", "name": "Quels symptômes peuvent nécessiter une imagerie 3D ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs persistantes, des anomalies visibles ou des symptômes neurologiques." } }, { "@type": "Question", "name": "L'imagerie 3D peut-elle aider à évaluer des douleurs abdominales ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle permet d'identifier des problèmes comme des tumeurs ou des malformations." } }, { "@type": "Question", "name": "Quels symptômes cardiaques peuvent être évalués par imagerie 3D ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs thoraciques ou des palpitations peuvent nécessiter une évaluation." } }, { "@type": "Question", "name": "L'imagerie 3D est-elle utile pour les troubles respiratoires ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle aide à visualiser les poumons et détecter des anomalies comme des nodules." } }, { "@type": "Question", "name": "Peut-on détecter des anomalies cérébrales avec l'imagerie 3D ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est efficace pour visualiser des anomalies comme des tumeurs ou des AVC." } }, { "@type": "Question", "name": "L'imagerie 3D peut-elle aider à la détection précoce des maladies ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle permet de détecter des maladies à un stade précoce, améliorant les chances de traitement." } }, { "@type": "Question", "name": "Comment l'imagerie 3D contribue-t-elle à la prévention des cancers ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet de surveiller les patients à risque et de détecter des anomalies précoces." } }, { "@type": "Question", "name": "Peut-on utiliser l'imagerie 3D pour le dépistage ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est utilisée pour le dépistage de certaines maladies comme le cancer du sein." } }, { "@type": "Question", "name": "L'imagerie 3D aide-t-elle à évaluer les risques cardiovasculaires ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle permet d'évaluer l'état des artères et de détecter des anomalies." } }, { "@type": "Question", "name": "Peut-on prévenir des maladies avec l'imagerie 3D ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Indirectement, en permettant une détection précoce et un suivi régulier." } }, { "@type": "Question", "name": "L'imagerie 3D est-elle utilisée pour planifier des interventions chirurgicales ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle permet de planifier avec précision les interventions chirurgicales." } }, { "@type": "Question", "name": "Comment l'imagerie 3D aide-t-elle en radiothérapie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet de cibler précisément les tumeurs tout en épargnant les tissus sains." } }, { "@type": "Question", "name": "Peut-on utiliser l'imagerie 3D pour guider des biopsies ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle aide à localiser précisément les zones à biopsier." } }, { "@type": "Question", "name": "L'imagerie 3D est-elle utile pour le suivi des traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle permet d'évaluer l'efficacité des traitements au fil du temps." } }, { "@type": "Question", "name": "Peut-on utiliser l'imagerie 3D pour des traitements non invasifs ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est utilisée pour des techniques comme l'ablation par radiofréquence." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec l'imagerie 3D ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des réactions allergiques aux agents de contraste ou des effets secondaires liés à l'exposition." } }, { "@type": "Question", "name": "L'imagerie 3D peut-elle causer des effets secondaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, notamment des effets liés à l'exposition aux radiations en cas de CT." } }, { "@type": "Question", "name": "Y a-t-il des risques liés à l'utilisation d'agents de contraste ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des réactions allergiques ou des problèmes rénaux peuvent survenir." } }, { "@type": "Question", "name": "L'imagerie 3D peut-elle entraîner des faux positifs ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies peuvent être détectées qui ne sont pas cliniquement significatives." } }, { "@type": "Question", "name": "Quelles sont les complications possibles après une biopsie guidée par imagerie 3D ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des saignements ou des infections peuvent survenir après la procédure." } }, { "@type": "Question", "name": "Quels facteurs augmentent le besoin d'imagerie 3D ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Antécédents familiaux de maladies, symptômes persistants ou exposition à des risques environnementaux." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque pour l'imagerie 3D ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées sont plus susceptibles de nécessiter des examens d'imagerie." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il le besoin d'imagerie 3D ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il augmente le risque de maladies pulmonaires nécessitant une évaluation." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils l'imagerie 3D ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies peuvent justifier des examens d'imagerie réguliers." } }, { "@type": "Question", "name": "Y a-t-il des facteurs environnementaux affectant l'imagerie 3D ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des substances toxiques peut augmenter le besoin d'examens." } } ] } ] }

Sources (10000 au total)

Unmet supportive care needs among cancer patients in Sub-Saharan African countries: a mixed method systematic review and meta-analysis.

Supportive cancer care is vital to reducing the current disparities in cancer outcomes in sub-Saharan Africa (SSA), including poor survival and low quality of life, and ultimately achieving equity in ... Six electronic databases [CINAHL, Embase, Medline (Ovid), PsycINFO, PubMed, and Cochrane Library of Databases] were systematically searched. Studies that addressed one or more domains of unmet support... Eleven articles out of 2732 were retained in the review. The pooled prevalence of perceived unmet need for cancer care in SSA was 63% (95% CI: 45, 81) for physical, 59% (95% CI: 45, 72) for health inf... In SSA, optimal cancer care provision was low, up to two-thirds of patients reported unmet needs for one or more domains. Strengthening efforts to develop comprehensive and integrated systems for supp...

Videolaryngoscopy use before and after the initial phases of the COVID-19 pandemic: The report of the VL-iCUE survey with responses from 96 countries.

The potential benefit of videolaryngoscopy use in facilitating tracheal intubation has already been established, however its use was actively encouraged during the COVID-19 pandemic as it was likely t... We sought to establish videolaryngoscopy use before and after the early phases of the pandemic, whether institutions had acquired new devices during the COVID-19 pandemic, and whether there had been t... We designed a survey with 27 questions made available via the Joint Information Scientific Committee JISC online survey platform in English, French, Spanish, Chinese, Japanese and Portuguese. This was... The survey was open for 54 to 90 days in various countries. The first responses were logged on the databases on 28 October 2021, with all databases closed on 26 January 2022. Reminders to participate ... All anaesthetists and airway managers who received the study were eligible to participate.... Videolaryngoscopy use before the COVID-19 pandemic and at the time of the survey.... We received 4392 responses from 96 countries: 944/4336 (21.7%) were from trainees. Of the 3394 consultants, 70.8% (2402/3394) indicated no change in videolaryngoscopy use, 19.9% (675/3394) increased u... Videolaryngoscopy use increased following the early phase of the COVID-19 pandemic but this was less than might have been expected....

Prognostic impact of pre-referral tumor resection in unilateral Wilms tumor: A single-institute experience from a lower middle-income country.

The objectives of this study were to evaluate the prognostic impact of pre-referral surgical resection of Wilms tumor (WT) performed at non-oncology centers, and to strategize an improved care plan fo... In this study conducted in a large pediatric cancer center in Pakistan, we retrospectively reviewed the electronic medical records (EMR) of 149 patients with unilateral WT from September 2008 to Augus... The proportion of metastatic disease in PTR and PCN groups was 33.3% and 35.1%, respectively. In the PTR subset, median time to admission after PTR was 5 weeks (mean 11, SEM 2.8, range: 2-202) weeks, ... Suboptimal pre-referral surgical intervention results in poor survival outcomes in unilateral WT. Our findings highlight the need for a comprehensive action plan for educating healthcare professionals...

Patient-reported outcomes before treatment for localized prostate cancer: are there differences among countries? Data from the True North Global Registry.

Similar Patient-Reported Outcomes (PROs) at diagnosis for localized prostate cancer among countries may indicate that different treatments are recommended to the same profile of patients, regardless t... We analyzed the EPIC-26 results before the primary treatment of men diagnosed of localized prostate cancer from January 2017 onwards (revised data available up to September 2019), from a multicenter p... The sample included a total of 13,483 men with clinically localized or locally advanced prostate cancer. PROs showed different domain patterns before treatment across countries. The sexual domain was ... Patients with localized or locally advanced prostate cancer undergoing radical prostatectomy, EBRT, brachytherapy, or active surveillance presented mainly negligible or small differences in the EPIC-2...

Physician- and Patient-Reported Severity and Quality of Life Impact of Alopecia Areata: Results from a Real-World Survey in Five European Countries.

Alopecia areata (AA) can negatively affect quality of life (QoL) and is associated with increased prevalence of anxiety and depression (vs people without AA). This study compared physician-assessed an... Real-world data were collected from the Adelphi Real World AA Disease Specific Programme™, a retrospective point-in-time cross-sectional survey of dermatologists and their adult patients with AA in fi... Data for 2083 patients were collected by 239 physicians; 561 of these patients completed PRO questionnaires. In 78.5% of cases with available data (N = 549), there was alignment between patient and ph... These data highlight the significant impact that AA can have beyond hair loss, especially for patients with severe AA. There was substantial physician-patient alignment on severity assessment. Higher ...

Ageing in place or stuck in place: Preferred care setting for community-dwelling older persons in a low-resource country in Sub Saharan Africa.

Ageing in Place is the emerging social policy drive for long-term care coordination of older persons globally. This decision may be the only viable option in many low- and middle-income countries like... The study utilised a mixed-methods approach. Participants were older persons (≥ 60 years) in a selected rural and urban community in Oyo State, south-western Nigeria. Quantitative data were collected ... 1,180 participants (588 rural vs 592 urban) were interviewed with a mean age of 73.2 ±9.3 years. More rural participants preferred to AIP (61.6%) compared to urban participants (39.2%), p = 0.001. Fac... Ageing in place is preferred and influenced by advanced age and home ownership in our setting. Information provided could guide age-friendly housing policies and community-based programmes for the car...

Are more physical education classes related to less time in leisure-time sedentary behavior? An analysis including adolescents from 73 countries.

This study aimed to verify the association between the weekly frequency of physical education (PE) classes and leisure sitting time among adolescents. We analyzed data from 73 countries using the Glob...

Exploring the health information-seeking practices of breast cancer patients in a middle-income country with a diverse ethnic population: a cross-sectional investigation.

Seeking health information is an important step for cancer patients to understand their condition and facilitate treatment. It also helps them deal with the unknown and aid in recovery. Therefore, it ...